263 related articles for article (PubMed ID: 31673919)
1. The actinobacterium Tsukamurella paurometabola has a functionally divergent arylamine N-acetyltransferase (NAT) homolog.
Garefalaki V; Kontomina E; Ioannidis C; Savvidou O; Vagena-Pantoula C; Papavergi MG; Olbasalis I; Patriarcheas D; Fylaktakidou KC; Felföldi T; Márialigeti K; Fakis G; Boukouvala S
World J Microbiol Biotechnol; 2019 Oct; 35(11):174. PubMed ID: 31673919
[TBL] [Abstract][Full Text] [Related]
2. Fusarium verticillioides NAT1 (FDB2) N-malonyltransferase is structurally, functionally and phylogenetically distinct from its N-acetyltransferase (NAT) homologues.
Karagianni EP; Kontomina E; Lowe ED; Athanasopoulos K; Papanikolaou G; Garefalaki V; Kotseli V; Zaliou S; Grimaud T; Arvaniti K; Tsatiri MA; Fakis G; Glenn AE; Roversi P; Abuhammad A; Ryan A; Sim RB; Sim E; Boukouvala S
FEBS J; 2023 May; 290(9):2412-2436. PubMed ID: 36178468
[TBL] [Abstract][Full Text] [Related]
3. Polymorphism p.Val231Ile alters substrate selectivity of drug-metabolizing arylamine N-acetyltransferase 2 (NAT2) isoenzyme of rhesus macaque and human.
Tsirka T; Boukouvala S; Agianian B; Fakis G
Gene; 2014 Feb; 536(1):65-73. PubMed ID: 24333853
[TBL] [Abstract][Full Text] [Related]
4. Arylamine N-acetyltransferases: a pharmacogenomic approach to drug metabolism and endogenous function.
Sim E; Pinter K; Mushtaq A; Upton A; Sandy J; Bhakta S; Noble M
Biochem Soc Trans; 2003 Jun; 31(Pt 3):615-9. PubMed ID: 12773167
[TBL] [Abstract][Full Text] [Related]
5. Comparative Investigation of 15 Xenobiotic-Metabolizing
Garefalaki V; Papavergi MG; Savvidou O; Papanikolaou G; Felföldi T; Márialigeti K; Fakis G; Boukouvala S
Appl Environ Microbiol; 2021 Sep; 87(19):e0081921. PubMed ID: 34288706
[TBL] [Abstract][Full Text] [Related]
6. Functional and structural characterization of the arylamine N-acetyltransferase from the opportunistic pathogen Nocardia farcinica.
Martins M; Pluvinage B; Li de la Sierra-Gallay I; Barbault F; Dairou J; Dupret JM; Rodrigues-Lima F
J Mol Biol; 2008 Nov; 383(3):549-60. PubMed ID: 18778714
[TBL] [Abstract][Full Text] [Related]
7. Arylamine N-acetyltransferases: from structure to function.
Sim E; Walters K; Boukouvala S
Drug Metab Rev; 2008; 40(3):479-510. PubMed ID: 18642144
[TBL] [Abstract][Full Text] [Related]
8. Divergence of cofactor recognition across evolution: coenzyme A binding in a prokaryotic arylamine N-acetyltransferase.
Fullam E; Westwood IM; Anderton MC; Lowe ED; Sim E; Noble ME
J Mol Biol; 2008 Jan; 375(1):178-91. PubMed ID: 18005984
[TBL] [Abstract][Full Text] [Related]
9. Structural and biochemical characterization of an active arylamine N-acetyltransferase possessing a non-canonical Cys-His-Glu catalytic triad.
Kubiak X; Li de la Sierra-Gallay I; Chaffotte AF; Pluvinage B; Weber P; Haouz A; Dupret JM; Rodrigues-Lima F
J Biol Chem; 2013 Aug; 288(31):22493-505. PubMed ID: 23770703
[TBL] [Abstract][Full Text] [Related]
10. Arylamine N-acetyltransferases: what we learn from genes and genomes.
Boukouvala S; Fakis G
Drug Metab Rev; 2005; 37(3):511-64. PubMed ID: 16257833
[TBL] [Abstract][Full Text] [Related]
11. Cloning and molecular characterization of three arylamine N-acetyltransferase genes from Bacillus anthracis: identification of unusual enzymatic properties and their contribution to sulfamethoxazole resistance.
Pluvinage B; Dairou J; Possot OM; Martins M; Fouet A; Dupret JM; Rodrigues-Lima F
Biochemistry; 2007 Jun; 46(23):7069-78. PubMed ID: 17511472
[TBL] [Abstract][Full Text] [Related]
12. Xenobiotic-metabolizing enzymes in Bacillus anthracis: molecular and functional analysis of a truncated arylamine N-acetyltransferase isozyme.
Kubiak X; Duval R; Pluvinage B; Chaffotte AF; Dupret JM; Rodrigues-Lima F
Br J Pharmacol; 2017 Jul; 174(14):2174-2182. PubMed ID: 27846346
[TBL] [Abstract][Full Text] [Related]
13. Molecular and Functional Characterization of N-Acetyltransferases NAT1 and NAT2 in Cynomolgus Macaque.
Uno Y; Murayama N; Yamazaki H
Chem Res Toxicol; 2018 Nov; 31(11):1269-1276. PubMed ID: 30358977
[TBL] [Abstract][Full Text] [Related]
14. Arylamine N-acetyltransferases: from drug metabolism and pharmacogenetics to drug discovery.
Sim E; Abuhammad A; Ryan A
Br J Pharmacol; 2014 Jun; 171(11):2705-25. PubMed ID: 24467436
[TBL] [Abstract][Full Text] [Related]
15. Insight into cofactor recognition in arylamine N-acetyltransferase enzymes: structure of Mesorhizobium loti arylamine N-acetyltransferase in complex with coenzyme A.
Xu X; Li de la Sierra-Gallay I; Kubiak X; Duval R; Chaffotte AF; Dupret JM; Haouz A; Rodrigues-Lima F
Acta Crystallogr D Biol Crystallogr; 2015 Feb; 71(Pt 2):266-73. PubMed ID: 25664736
[TBL] [Abstract][Full Text] [Related]
16. Identification of amino acids imparting acceptor substrate selectivity to human arylamine acetyltransferases NAT1 and NAT2.
Goodfellow GH; Dupret JM; Grant DM
Biochem J; 2000 May; 348 Pt 1(Pt 1):159-66. PubMed ID: 10794727
[TBL] [Abstract][Full Text] [Related]
17. The COOH terminus of arylamine N-acetyltransferase from Salmonella typhimurium controls enzymic activity.
Mushtaq A; Payton M; Sim E
J Biol Chem; 2002 Apr; 277(14):12175-81. PubMed ID: 11799105
[TBL] [Abstract][Full Text] [Related]
18. The pharmacogenetics of NAT: structural aspects.
Pompeo F; Brooke E; Kawamura A; Mushtaq A; Sim E
Pharmacogenomics; 2002 Jan; 3(1):19-30. PubMed ID: 11966400
[TBL] [Abstract][Full Text] [Related]
19. Redox regulation of the human xenobiotic metabolizing enzyme arylamine N-acetyltransferase 1 (NAT1). Reversible inactivation by hydrogen peroxide.
Atmane N; Dairou J; Paul A; Dupret JM; Rodrigues-Lima F
J Biol Chem; 2003 Sep; 278(37):35086-92. PubMed ID: 12832400
[TBL] [Abstract][Full Text] [Related]
20. Arylamine N-acetyltransferases: structural and functional implications of polymorphisms.
Sim E; Lack N; Wang CJ; Long H; Westwood I; Fullam E; Kawamura A
Toxicology; 2008 Dec; 254(3):170-83. PubMed ID: 18852012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]